Merck buys French digital animal identification solutions company Antelliq Group.

It was a big year for mergers and acquisitions, as predicted. What now? The trend can't last forever.

There's plenty at stake for biotech and managed care stocks in the November 6 election.

Global stocks are on track to close out one of the worst months since the financial crisis on a high note Wednesday, with investors cautiously moving cash into beaten-down equities that are trading at their cheapest levels in more than two years even as headline risks related to U.S.-China trade rising interest rates and weakening corporate earnings continue to challenge sentiment.

Jim Cramer takes a closer look at Express Scripts, Lockheed Martin, Raytheon, Abiomed.

Frequent riders of Uber are about to lose something they really like.

Amyris is showing progress in one key area, but it may not be enough.

The disgraced investor and convicted felon launched a cryptocurrency last July after his release from prison.

The National Highway Transit Safety Administration received over 50 complaints over brake hose ruptures.